Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine

被引:50
作者
Gopal, S
Tzeng, TB
Cowan, A
机构
[1] Temple Univ, Sch Pharm, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Philadelphia, PA 19140 USA
关键词
buprenorphine; norbuprenorphine; pharmacokinetics; volume of distribution; clearance; rat;
D O I
10.1016/S0928-0987(02)00009-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this project was to characterize the dose-dependent pharmacokinetics of buprenorphine (BN) and norbuprenorphine (NBN), the primary metabolite, after intravenous administration of different doses of BN to rats. Adult male Sprague-Dawley rats were divided into six groups and received a single intravenous bolus dose of 0.1, 0.3, 1, 3, 10 or 30 mg/kg of BN. A separate study was performed where BN and NBN were simultaneously administered intravenously (1 mg/kg + 1 mg/kg). Plasma samples were obtained by centrifugation of the blood and analyzed for BN and NBN using a sensitive and selective gas chromatographic-mass spectrometric (GC-MS) bio-analytical method. Noncompartmental and compartmental methods were used to perform pharmacokinetic data analysis. BN declined triexponentially with a dose-dependent increase in its volume of distribution, V-ss (8.37-18.2 1/kg) and clearance CL (2.70-6.10 1/h per kg). The pharmacokinetics of NBN were linear and biexponential. Coadministration of BN and NBN resulted in a significant increase in the volume of distribution and clearance of BN. The present results suggest that the nonlinear disposition in the clearance and volume of distribution of BN can be attributed, in part, to the increasing concentration of the metabolite. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 18 条
[1]   Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet [J].
Amass, L ;
Kamien, JB ;
Mikulich, SK .
DRUG AND ALCOHOL DEPENDENCE, 2000, 58 (1-2) :143-152
[2]   Buprenorphine Treatment of Opioid Dependence: A Review [J].
Bickel, Warren K. ;
Amass, Leslie .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1995, 3 (04) :477-489
[3]   ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT [J].
COWAN, A ;
DOXEY, JC ;
HARRY, EJR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :547-554
[4]   AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].
COWAN, A ;
LEWIS, JW ;
MACFARLANE, IR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545
[5]  
Cowan Alan, 1995, P31
[6]   Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma [J].
Gopal, S ;
Tzeng, TB ;
Cowan, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 51 (02) :147-151
[7]   Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance [J].
Greenwald, MK ;
Johanson, CE ;
Schuster, CR .
DRUG AND ALCOHOL DEPENDENCE, 1999, 56 (03) :191-203
[8]   Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbits [J].
Groll, AH ;
Sein, T ;
Petraitis, V ;
Petraitiene, R ;
Callender, D ;
Gonzalez, CE ;
Giri, N ;
Bacher, J ;
Piscitelli, S ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2700-2705
[9]  
JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501
[10]   BUPRENORPHINE TREATMENT OF OPIOID DEPENDENCE - CLINICAL-TRIAL OF DAILY VERSUS ALTERNATE-DAY DOSING [J].
JOHNSON, RE ;
EISSENBERG, T ;
STITZER, ML ;
STRAIN, EC ;
LIEBSON, IA ;
BIGELOW, GE .
DRUG AND ALCOHOL DEPENDENCE, 1995, 40 (01) :27-35